News

Readers of mainstream media reports on availability of the COVID-19 vaccine are likely to be confused as to when they themselves will be eligible to get the shot. Where the Boston Herald just reported that the general population might be eligible for immunization “by February,” Forbes posted an article saying that a quarter of the world’s population won’t be able to get the vaccine until 2022. They’re both likely to be correct. The Herald’s source …

With coronavirus vaccinations now being administered to the first round of recipients, the Centers for Disease Control and Prevention just issued a new advisory specifying groups who are deemed to be “safe” to receive the vaccine. Specifically, the CDC advises that adults with underlying health conditions and autoimmune conditions, as well as those with a history of Guillain-Barré syndrome and Bell’s palsy can be immunized. Last week, the CDC’s Advisory Committee on Immunization Practices voted …

We know that immunocompromised patients are at increased risk for all manner of infection, including COVID-19. We also know that patients with cancer fall under that broad umbrella. However, new research indicates that cancer patients, specifically, are at greater risk for infection and subsequent mortality due to the virus. This phenomenon seems to be especially prevalent in those recently diagnosed with leukemia, lung cancer, and non–Hodgkin lymphoma, according to a study just published in JAMA …

Some corners of the public seem to have fallen back into the notion that, while patients with comorbid conditions are at higher risk, a case of COVID-19 is not that different from a bad case of influenza—you feel bad for a week or two and then you’re back on your feet. New data published in the Annals of Internal Medicine should help you disavow them of that misconception, however. An article there indicates that up …

The United States is already grappling with a deadly resurgence of the COVID-19 virus, but news from the United Kingdom indicates we could see a dire situation turn even worse if we’re not careful. The government there, perhaps wary of repeating mistakes that allowed the virus to run rampant last spring, has already implemented a partial shutdown of nonessential businesses and services in order to discourage widespread contact among the public. This is not “just” …

A pair of new COVID-19 self-test kits received approval from the Food and Drug Administration this week. The biggest—and possibly most concerning—difference between the two is that one is available without a prescription. The first, BinaxNOW from Abbott, was already approved for, and being administered by, healthcare professionals. Now, however, patients who want to be tested can log on to an Abbott app with their smartphone to be connected to a healthcare provider at eMed. …